Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Change in Inventory (2018 - 2025)

Historic Change in Inventory for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q3 2025 value amounting to $14000.0.

  • CollPlant Biotechnologies' Change in Inventory rose 19333.33% to $14000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$82000.0, marking a year-over-year decrease of 10731.49%. This contributed to the annual value of $280000.0 for FY2024, which is 6261.68% down from last year.
  • Per CollPlant Biotechnologies' latest filing, its Change in Inventory stood at $14000.0 for Q3 2025, which was up 19333.33% from $120000.0 recorded in Q2 2025.
  • In the past 5 years, CollPlant Biotechnologies' Change in Inventory registered a high of $856000.0 during Q4 2023, and its lowest value of -$345000.0 during Q1 2023.
  • Its 5-year average for Change in Inventory is $45421.1, with a median of $15000.0 in 2024.
  • As far as peak fluctuations go, CollPlant Biotechnologies' Change in Inventory tumbled by 133076.92% in 2022, and later skyrocketed by 37435.9% in 2023.
  • CollPlant Biotechnologies' Change in Inventory (Quarter) stood at $181000.0 in 2021, then tumbled by 272.38% to -$312000.0 in 2022, then soared by 374.36% to $856000.0 in 2023, then crashed by 98.25% to $15000.0 in 2024, then decreased by 6.67% to $14000.0 in 2025.
  • Its last three reported values are $14000.0 in Q3 2025, $120000.0 for Q2 2025, and -$231000.0 during Q1 2025.